Biomarkers may indicate severity of COVID in children
October 15, 2021
"A model of six miRNAs was able to discriminate between severe and nonsevere infections with high sensitivity and accuracy in a preliminary analysis."
COVID-19 mitigation measures led to shifts in typical annual respiratory virus patterns
August 11, 2021
“Clinicians should be aware of increases in some respiratory virus activity and remain vigilant for off-season increases.”
C. Diff eradication not necessary for clinical cure of recurrent infections with fecal transplant
July 27, 2021
“I think the advice should be: Give a full anti–C. diff antibiotic course to treat the C. diff infection, and then give FMT afterward to restore the microbiota.”
Long COVID seen in patients with severe and mild disease
July 20, 2021
A Swiss study shows how even mild COVID cases can lead to debilitating symptoms, according to Dr. Christopher Terndrup.
Early heparin treatment linked to lower COVID-19 mortality
July 15, 2021
Rates of death were significantly lower by almost half in patients who received early heparin than in those who did not.
Standard medical mask can protect wearer from aerosols
July 12, 2021
Although this study showed how well different masks filtered out particles, it could not assess how well different masks prevent actual infection.
New guidelines on antibiotic prescribing focus on shorter courses
April 6, 2021
“Many physicians do not prescribe short-course therapy, frequently defaulting to 10-day courses regardless of the condition.”
MIS-C follow-up proves challenging across pediatric hospitals
March 8, 2021
First came the challenge of figuring out the best treatment regimen for patients with MIS-C. Then physicians had to think about follow-up.
Sepsis readmissions risk linked to residence in a poor neighborhoods
July 1, 2020
Patients who live in disadvantaged neighborhoods may not have access to healthy food and safe housing.
ACR issues guidances for MIS-C and pediatric rheumatic disease during pandemic
June 23, 2020
The ACR appears to be the first medical organization to review all the most current evidence to issue interim guidance with the expectations that it will change as more data become available.